KDT-3594
- Generic Name
- KDT-3594
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
KDT-3594 is a non-ergot dopamine receptor agonist developed by Kissei Pharmaceutical.
- Associated Conditions
- -
- Associated Therapies
- -
A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT06722729
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2022-05-11
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 7
- Registration Number
- NCT04867551
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 74
- Registration Number
- NCT03845387
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT03068481
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath